← Browse by Condition
Medical Condition
hypopharynx cancer
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 3, Phase 2
NCT06706401 Phase 3
Recruiting
Lymphocyte-Sparing And Radio-Immunotherapy in Head and Neck Carcinoma
Enrollment
460 pts
Location
France
Sponsor
Centre Leon Berard
NCT07063212 Phase 2
Recruiting
A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)
Enrollment
40 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance...